What is the probability of HIV acquisition from a percutaneous needle‑stick injury with a hollow‑bore needle that passed through nitrile gloves from an HIV‑positive source?

Probability of HIV Acquisition from Percutaneous Needlestick Injury Through Gloves

The probability of HIV transmission from a hollow-bore needlestick injury that penetrated nitrile gloves from an HIV-positive source is approximately 0.3% (3 per 1,000 exposures), though this baseline risk can be modified by several exposure characteristics. 1

Baseline Transmission Risk

• The average risk for HIV transmission after percutaneous exposure to HIV-infected blood is 0.3% (95% CI = 0.2%–0.5%) based on prospective studies of healthcare workers. 1
• This translates to approximately 3 infections per 1,000 needlestick exposures to HIV-contaminated blood. 2
• For comparison, the risk of hepatitis B transmission from a similar exposure is 6-30%, making HIV transmission substantially less likely than HBV. 1, 3

Factors That Increase Risk in Your Scenario

The presence of a hollow-bore needle significantly increases transmission risk compared to solid needles, as hollow-bore needles transfer larger volumes of blood. 1

Several factors can elevate the baseline 0.3% risk:

• Deep injury increases risk 15-fold (odds ratio = 15; 95% CI, 6.0–41). 4
• Visible blood on the device increases risk 6-fold (odds ratio = 6.2; 95% CI, 2.2–21). 4
• Needle placed directly in a vein or artery of the source patient increases risk 4-fold (odds ratio = 4.3; 95% CI, 1.7–12). 4
• Source patient with terminal AIDS or who died within 2 months increases risk 6-fold (odds ratio = 5.6; 95% CI, 2.0–16), likely reflecting higher viral load. 4

Effect of Glove Penetration

• The fact that the needle passed through nitrile gloves may slightly reduce the inoculum size, as some blood may be wiped off during passage through the glove material. 1
• However, hollow-bore needles retain blood in their lumen, so glove penetration provides limited protection compared to solid needles. 1
• The baseline 0.3% risk estimate already includes many exposures where gloves were worn, so do not assume the glove substantially lowered your risk. 4

Critical Management Steps

Initiate post-exposure prophylaxis (PEP) immediately—ideally within 24 hours and no later than 72 hours—as PEP reduces transmission risk by approximately 81% (odds ratio = 0.19; 95% CI, 0.06–0.52). 4, 5

• Wash the injury site immediately with soap and water without squeezing or applying caustic agents. 6
• Start a 28-day course of combination antiretroviral therapy as soon as possible. 2
• Do not delay PEP initiation while awaiting source patient testing; effectiveness declines dramatically after 72 hours. 2
• Preferred regimens include bictegravir/emtricitabine/tenofovir alafenamide or dolutegravir-based combinations. 2

Testing Protocol

• Obtain baseline HIV testing before starting PEP (but do not delay the first dose). 2
• Follow-up testing at 6 weeks, 12 weeks, and potentially 6 months post-exposure. 2
• Complete the full 28-day PEP course even if side effects occur; anti-nausea medications can improve adherence. 2

Common Pitfalls to Avoid

• Do not assume the glove provided significant protection—hollow-bore needles retain blood internally. 1
• Do not wait beyond 72 hours to seek medical evaluation; PEP effectiveness drops sharply after this window. 2
• Do not stop PEP prematurely; the full 28-day course is essential for maximum protection. 2
• Do not attempt to test the needle itself for HIV; this is unreliable and wastes critical time. 2